360Dx

UMass

Oct 06, 2020

BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization

BioFire's test is designed to detect and differentiate between SARS-CoV-2 and other respiratory pathogens, while UMass Medical's test is only for SARS-CoV-2.

Menu

UMass

BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization

Breaking News

Novacyt in Dispute with UK Department of Health and Social Care Over Coronavirus Test Contract

In Brief This Week: Bio-Techne, Mologic, Caris Life Sciences, And More

BioMérieux Gets CE Mark for Three Dengue Immunoassays

Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M

LumiraDx to Go Public on Nasdaq Through SPAC

Roche Elecsys Anti-p53 Test for Cancer Diagnosis Earns CE Mark